Top Ranked Momentum Stocks to Buy for May 15th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 15th:
Halozyme Therapeutics, Inc. (HALO): This biopharma technology platform company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 17.2% over the last 60 days.
Halozyme Therapeutics, Inc. Price and Consensus
Halozyme Therapeutics, Inc. price-consensus-chart | Halozyme Therapeutics, Inc. Quote
Halozyme Therapeutics’ shares gained 28.6% over the last one month compared with the S&P 500 growth 5%. The company possesses a Momentum Score of A.
Halozyme Therapeutics, Inc. Price
Halozyme Therapeutics, Inc. price | Halozyme Therapeutics, Inc. Quote
II-VI Incorporated (IIVI): This company that develops, manufactures, and markets engineered materials, and optoelectronic components and devices has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 30.3% over the last 60 days.
IIVI Incorporated Price and Consensus
IIVI Incorporated price-consensus-chart | IIVI Incorporated Quote
II-VI’s shares gained 41.4% over the last one month. The company possesses a Momentum Score of A.
IIVI Incorporated Price
IIVI Incorporated price | IIVI Incorporated Quote
Kopin Corporation (KOPN): This company that invents, develops, manufactures, and sells components, subassemblies, head-worn, and hand-held systems has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.6% over the last 60 days.
Kopin Corporation Price and Consensus
Kopin Corporation price-consensus-chart | Kopin Corporation Quote
Kopin’s shares gained 94.2% over the last one month. The company possesses a Momentum Score of A.
Kopin Corporation Price
Kopin Corporation price | Kopin Corporation Quote
MEI Pharma, Inc. (MEIP): This late-stage pharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
MEI Pharma, Inc. Price and Consensus
MEI Pharma, Inc. price-consensus-chart | MEI Pharma, Inc. Quote
MEI Pharma’s shares gained 18.6% over the last one month. The company possesses a Momentum Score of A.
MEI Pharma, Inc. Price
MEI Pharma, Inc. price | MEI Pharma, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Zacks Top 10 Stocks for 2020
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?
Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2020 today >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
MEI Pharma, Inc. (MEIP) : Free Stock Analysis Report
Kopin Corporation (KOPN) : Free Stock Analysis Report
IIVI Incorporated (IIVI) : Free Stock Analysis Report
Halozyme Therapeutics, Inc. (HALO) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
